Companies: 10,795·Total market cap: $144.5T
Alumis Inc. Common Stock

Alumis Inc. Common Stock

ALMSNASDAQHealthcare● Active
$18.97
$-0.09(-0.49%)
Market Cap$2.3B
P/E Ratio
52W High$30.6
52W Low$2.76

Alumis Inc. Common Stock (ALMS) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · ALMS · as of Mar 19, 2026

Latest filing snapshot

221
+51+30.00%vs prior year

Alumis Inc. Common Stock (ALMS) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing

SEC 10-K·Period end: 2025-12-31·Full-time · Global
Total Employees
221
Change (1Y)
+51
Growth % (1Y)
+30.00%
Revenue / Employee
$108.8K
Net Income / Employee
$-1.10M
Market Cap
$2.3B

ALMS Employee Count

2024 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing DateEmployeesChange (1Y)Growth (1Y)SEC filing link
2026-03-19221+51+30.00%
2025-03-19170

Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology
#SymbolCompanyEmployees
#1
Bicycle Therapeutics plc
BCYC
Bicycle Therapeutics plc
305
#2
ADC Therapeutics S.A.
ADCT
ADC Therapeutics S.A.
263
#3
Alumis Inc. Common Stock
ALMS
Alumis Inc. Common StockYOU
221
#4
Lexicon Pharmaceuticals, Inc.
LXRX
Lexicon Pharmaceuticals, Inc.
103
#5
Lineage Cell Therapeutics, Inc.
LCTX
Lineage Cell Therapeutics, Inc.
70
#6
Fulcrum Therapeutics, Inc.
FULC
Fulcrum Therapeutics, Inc.
45
#7
Eton Pharmaceuticals, Inc.
ETON
Eton Pharmaceuticals, Inc.
31
Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · ALMS peer comparison

About ALMS employees

ALMS Employees · Headcount

Alumis Inc. Common Stock (ALMS) employee data is sourced from the annual SEC 10-K filing. As of 2025, Alumis Inc. Common Stock had 221 full-time employees globally. Full-time employees only. Global consolidated headcount.

Alumis Inc. Common Stock employs 221 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $108,824, reflecting the company's operational efficiency.

Alumis Inc. Common Stock's workforce increased by 51 (30.00%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Alumis Inc. Common Stock's revenue per employee of $108,824 positions it among the notable performers in the Biotechnology sector for operational efficiency.

Frequently Asked Questions

ALMS Employees · 5 questions

As of the latest SEC 10-K filing (2025), Alumis Inc. Common Stock had 221 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Alumis Inc. Common Stock employee counthow many employees does Alumis Inc. Common Stock haveALMS total employees 2025

Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-03-19